1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)-

1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)- Struktur
2270173-63-0
CAS-Nr.
2270173-63-0
Englisch Name:
1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)-
Synonyma:
Upatinib impurity 50;Upadacitinib Impurity 53;Upadacitinib Impurity 25(Dihydrochloride);3-ethyl-8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine;benzyl (3S,4R)-3-ethyl-4-((5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)glycyl)pyrrolidine-1-carboxylate;1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)-
CBNumber:
CB48358460
Summenformel:
C29H31N5O5S
Molgewicht:
561.65
MOL-Datei:
2270173-63-0.mol

1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)- Eigenschaften

Siedepunkt:
766.2±70.0 °C(Predicted)
Dichte
1.36±0.1 g/cm3(Predicted)
pka
3.13±0.30(Predicted)

Sicherheit

1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)- Chemische Eigenschaften,Einsatz,Produktion Methoden

1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ShenZhen H&D Pharmaceutical Technology Co., LTD
+8618627948422
sale@hdimpurity.com China 3389 58
Shijiazhuang yaoBo Pharmaceutical Co., Ltd. 15633056635
2880679888@qq.com China 2872 58
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd. 0531-58897130 15508676053
drug_impurity@sdcclh.com China 1932 58
Molcoo Chemicals Inc. 18672515910
3001051413@qq.com China 9264 58
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725
malulu@leyan.com China 39990 58
Tianjin Hengze Pharmaceutical Technology Co. , Ltd. 022-20629054 15620629054
Iyding@medhonor.com.cn China 78 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 13986652530
zhangweiyue@hdimpurity.com China 4140 58
Hubei Moco Chemical Co., Ltd. 18627753421 18627753421
3001009495@qq.com China 10987 58
Wuhan Circle Star Chem-medic Technology Co.,Ltd 15927172400 15927172400
marketing@circlestar-chem.com China 2998 58

  • 1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)-
  • benzyl (3S,4R)-3-ethyl-4-((5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)glycyl)pyrrolidine-1-carboxylate
  • Upatinib impurity 50
  • 3-ethyl-8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine
  • Upadacitinib Impurity 53
  • Upadacitinib Impurity 25(Dihydrochloride)
  • 2270173-63-0
  • 17089978-42-5
Copyright 2019 © ChemicalBook. All rights reserved